ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea · Delayed Price · Currency is KRW 1,846.00
-37.00 (-1.96%)
At close: Oct 23, 2026
KOSDAQ:034940 Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 61,162 | 59,311 | 62,694 | 62,974 | 68,880 | 57,561 |
Revenue Growth | 1.50% | -5.40% | -0.45% | -8.57% | 19.66% | -11.93% |
Gross Profit Gross Profit Growth | 22,566 | 21,874 | 21,199 | 23,761 | 26,242 | 20,309 |
Operating Income Operating Income Growth | -4,133 | -6,598 | -9,828 | -8,792 | -482.21 | -7,003 |
Net Income Net Income Growth | -2,812 | -6,806 | -9,605 | -10,514 | 560.69 | -8,044 |
Earnings Per Share EPS Growth | -453.69 | -1098.42 | -1550.12 | -1696.97 | 90.49 | -1298.21 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Korea Korea Growth | 63,223 | 61,666 | 65,412 | 65,756 | 72,040 | 60,402 |
Vietnam Vietnam Growth | 19.27 | 26.26 | 56.32 | 53.37 | 83.57 | 56.38 |
Elimination of Internal Transactions Elimination of Internal Transactions Growth | -2,080 | -2,381 | -2,775 | -2,835 | -3,244 | -2,897 |
Total Total Growth | 61,162 | 59,311 | 62,694 | 62,974 | 68,880 | 57,561 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,367 | 2,523 | 5,447 | 4,361 | 8,449 | 10,184 |
Total Debt Total Debt Growth | 26,952 | 27,305 | 24,689 | 17,501 | 18,678 | 16,474 |
Net Cash (Debt) Net Cash Growth | -24,585 | -24,782 | -19,242 | -13,141 | -10,229 | -6,289 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3967.04 | -3999.75 | -3105.52 | -2120.83 | -1650.84 | -1015.09 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -1,798 | -4,180 | -4,468 | -1,475 | -1,443 | -1,480 |
Capital Expenditures CapEx Growth | -1,061 | -1,986 | -551.31 | -831.13 | -2,782 | -3,544 |
Free Cash Flow Free Cash Flow Growth | -2,859 | -6,165 | -5,019 | -2,306 | -4,225 | -5,024 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.90% | 36.88% | 33.81% | 37.73% | 38.10% | 35.28% |
Operating Margin | -6.76% | -11.13% | -15.68% | -13.96% | -0.70% | -12.17% |
Pretax Margin | -4.11% | -10.83% | -16.00% | -17.36% | -0.62% | -12.42% |
Profit Margin | -4.60% | -11.47% | -15.32% | -16.70% | 0.81% | -13.97% |
FCF Margin | -4.67% | -10.39% | -8.01% | -3.66% | -6.13% | -8.73% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 130.12 | - |
PS Ratio | 0.19 | 0.53 | 0.48 | 0.98 | 1.06 | 2.02 |